Enhancement of Attention Processing by Kantroll™ in Healthy Humans: A Pilot Study

Clinical EEG and Neuroscience

Volumn 28, Issue 2, 1997, Pages 68-75

  Defrance, Jon F ^a,b   Hymel, Chris ^a,c   Trachtenberg, Michael C ^d   Ginsberg, Lawrence D ^e   Schweitzer, Forrest C ^b   Estes, Steven ^b   Chen, Thomas J H ^g   Braverman, Eric R ^f   Cull, John G ^h   Blum, Kenneth ^h,i,j  

^a UNIVERSITY OF TEXAS   (United States)

^b Gulf Pines Hospital   (United States)

^c CH Systems   (United States)

^d Team Health Southwest   (United States)

^e Red Oak Psychiatry Associates   (United States)

^f University School of Medicine   (United States)

^g CHANG JUNG CHRISTIAN UNIVERSITY   (Taiwan)

^h Kantroll Inc   (United States)

ⁱ Department of Behavioral Sciences ^*  (United States)

^j UNIVERSITY OF TEXAS   (United States)

more..

Author keywords

Amino Acids; Attention; Enkephalinase Inhibition; Event Related Potentials; Kantroll ; P300

Indexed keywords

4 AMINOBUTYRIC ACID; ADRENALIN; COCAINE; DOPAMINE; GLYCINE; KANTROLL; MELATONIN; NORADRENALIN; SEROTONIN; TROPAMINE; UNCLASSIFIED DRUG;

ADDICTION; ADULT; AMINO ACID METABOLISM; ARTICLE; ATTENTION; ELECTROENCEPHALOGRAM; EVENT RELATED POTENTIAL; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; MALE; MOOD; NEUROTRANSMISSION; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SPATIAL ORIENTATION; TASK PERFORMANCE;

ADULT; AMINO ACIDS; ATTENTION; ELECTROENCEPHALOGRAPHY; EVENT-RELATED POTENTIALS, P300; HUMANS; MALE; MINERALS; PILOT PROJECTS; TASK PERFORMANCE AND ANALYSIS; VITAMINS;

EID: 0030951204     PISSN: 15500594     EISSN: None     Source Type: Journal    
DOI: 10.1177/155005949702800204     Document Type: Article

References (41)

1. Wurtman RJ Food consumption, neurotransmitter synthesis, and human behavior. Experientia 1983; 44: 356-369.
2. Wurtman RJ Hefti F Melamed E. Precursor control of neurotransmitter synthesis. Pharmacol Rev 1981; 2: 315-335.
3. Hernandez L Lee F Hoebel BG Microdialysis in the nucleus accumbens during feeding or drugs of abuse: Amphetamine, cocaine, and phencyclidine. In: Kalivas PW, Nemeroff CB,(eds). The Meso-corticolimbic Dopamine System. New York: New York Academy of Sciences; 1988: 508-511.
4. Blum K Wallace JE Geller I. Synergy of ethanol and putative neurotransmitters: Glycine and serine. Science 1972; 176: 292-294.
5. Ehrenpreis S Balagot RC Comaty JE Myles SB Naloxone reversible analgesia in mice produced by D-phenylalanine and hydrocinnamic acid, inhibitors of carboxypeptidase A. In: Bonica JJ, etal(eds). Advances in Pain and Research Therapy. New York: Raven Press; 1979: 479-488.
6. Amit C Brown ZW Actions of drugs of abuse on brain reward systems: A reconsideration with specific attention to alcohol. Pharmacol Biochem Behav 1982; 17: 233-238.
7. Blum K Noble EP Sheridan PJ, et al. Allelic association of human dopamine D2 receptor gene in alcoholism. JAMA 1990; 263: 2055-2060.
8. Koob GF Bloom FE. Cellular and molecular mechanisms of drug dependence. Science 1988; 242: 715-723.
9. Wise RA Bozarth MA Action of abused drugs on reward systems in the brain. In: Blum K, Manzo L,(eds). Neurotoxicology. New York: Marcel Dekker; 1985: 111-133.
10. Williams RJ Alcoholism: The Nutritional Approach. Austin: University of Texas Press; 1959.
11. Blum K Briggs AH Trachtenberg MC Ethanol ingestive behavior as a function of central neurotransmission (Review). Experientia 1989; 45: 444-452.
12. Blum K Allison D Trachtenberg MC Williams RW Loeblich LA Reduction of both drug hunger and withdrawal against advice rate of cocaine abusers in a 30-day inpatient treatment program by the neuronutrient Tropamine. Cur Therap Res 1988; 43: 1204-1214.
13. Begleiter H Porjesz B. Neuroelectric processes in individuals at risk for alcoholism. Alcohol Alcoholism 1990; 25: 251-256.
14. Whipple S Parker ES Noble EP An atypical neurocognitive profile in alcoholic fathers and their sons. J Studies Alcohol 1988; 49: 240-244.
15. Corbetta M Miezin FM Dobmeyer S Shulman GL Petersen SE Selective and divided attention during visual discriminations of shape, color, and speed: Functional anatomy by positron emission tomography. J Neurosci 1991; 11: 2383-2402.
16. Cohen RM Semple WE Gross M, et al. Dysfunction in a prefrontal substrate of sustained attention in schizophrenia. Life Sciences 1987; 40: 2031-2039.
17. Posner MI Presti DE Selective attention and cognitive control. Trends Neurosci 1987; 10: 13-17.
18. Gangadhar BN Ancy J Janakiramaiah N Umapathy C. P300 amplitude in nonbipolar, melancholic depression. J Affect Disord 1993; 28: 57-60.
19. Posner MI Cohen Y Rafal RD Neural systems control of spatial orienting. Philosophical Transactions of the Royal Society of London 1982; 298: 187-198.
20. Posner MI Early TS Reiman E Pardo PJ Dhawan M. Asymmetries in hemispheric control of attention in schizophrenia. Arch Gen Psychiatry 1988; 45: 814-821.
21. DeFrance JF Hymel C Degioanni J, et al. Evidence of temporal lobe activation by discriminative spatial orientation. Brain Topography 1993; 6: 137-142.
22. Rosvold NE Mirsky AF Sarason I Barnsome ED Beck LH A continuous-performance test of brain damage. J Consult Psychol 1956; 20: 343-352.
23. DeFrance JF Smith S Schweitzer FC Ginsberg L Sands S. Topographical mapping of attention disorders of childhood. Internat J Neurosci 1996; 87: 41-61.
24. Sostek AJ Buchsbaum MS Rapoport JL Effects of amphetamine on vigilance performance in normal and hyperactive children. J Abnorm Child Psychol 1980; 8: 491-500.
25. Duffy FH Bartels PD Burchfield JL Significance probability mapping: An aid in the topographical analysis of brain electrical activity. Electroencephalogr Clin Neurophysiol 1981; 51: 455-462.
26. Ritter W Simpson R Vaughan HG Jr. Event-related potential correlates of two stages of information processing in physical and semantic discrimination tasks. Psychophysiol 1983; 20: 168-179.
27. Donchin E Callaway E Cooper R, et al. Publication criteria for studies of evoked potentials (EP) in man. Report of the methodology committee. In: Desmedt JE,(ed). Attention, Voluntary Contraction and Event Related Cerebral Potentials: Progress in Clinical Neurophysiology. Basel: Karger; 1977: 1-11.
28. Halgren E Smith ME Cognitive evoked potentials as modulatory processes in human memory formation and retrieval. Hum Neurobiol 1987; 6: 129-139.
29. Halgren E Squires NK Wilson CL Rohrbaugh JW Babb TL Crandall PH Endogenous potentials generated in the human hippocampal formation and amygdala by infrequent events. Science 1980; 210: 803.
30. Sutton S Braren M Zubin J John ER Evoked potential correlates of stimulus uncertainty. Science 1965; 150: 1961-1969.
31. Roleda P Kaneko WM Ehlers CL The effects of acute cocaine administration on auditory event-related potentials in rats. Neurosci Letters 1993; 160: 4-8.
32. Hillyard SA Hink RF Schwent VL Picton TW Electrical signs of selective attention in the human brain. Science 1973; 182: 177-180.
33. Stanzione P Fattapposta F Tagliati M, et al. Dopaminergic pharmacological manipulations in normal humans confirm the specificity of the visual (PERGVEP) and cognitive (P300) electrophysiological alternations in Parkinson's Disease. Electroencephalogr Clin Neurophysiol 1990; 44: 447-448.
34. Blum K. A commentary on neurotransmitter restoration as a common mode of treatment for alcohol, cocaine and opiate abuse. Integrat Psychiat 1989; 6: 199-204.
35. Blum K Payne JE Alcohol and the Addictive Brain. New York: Free Press; 1991.
36. Trachtenberg MC Blum K. Improvement of cocaine-induced neuromodulator deficits by neuronutrient tropamine. J Psychoact Drugs 1988; 20: 315-331.
37. Blum K Kozlowski GP Ethanol and neuromodulator interactions: A cascade model of reward. In: Ollat J, etal(eds). Progress Alcohol Research II. Utrecht: VSP; 1990: 131-149.
38. Blum K Cull JG Braverman ER Gommings DE Reward deficiency syndrome. Amer Sci 1996; 84: 132-145.
39. Blum K Sheridan PJ Wood RC, et al. The D2 dopamine receptor gene as a determinant of reward deficiency syndrome. J Royal Soc Med. 1996; 89: 396-400.
40. Braverman ER Blum K. Substance use disorder exacerbates brain electrophysiological abnormalities in a psychiatrically-ill populaton. Clin Electroencephalogr 1996 (Suppl); 27: 2-28.
41. Cold JA NeuRecover-SA™ in the treatment of cocaine withdrawal and craving: A pilot study. Clin Drug Invest 1996; 12: 1-7.